Aesthetic Medicine Articles & Analysis
10 news found
Hyperpigmentation dermatoses are a common clinical problem today, including freckles, nevus of Ota, age spots and coffee spots, which have a significant impact on patients' facial aesthetics and psychological well-being. Traditionally, patients with pigmentation disorders have been treated with implants, grinding and freezing, but these treatment options are prone to ...
Picosecond laser technology is a highly sought-after treatment in the field of medical aesthetics that can effectively treat all types of skin blemishes. The treatment of blemishes has long been one of the most difficult problems in the field of medical aesthetics and with the use of picosecond laser technology, there is finally a simple and effective solution to ...
A valid alternative to liposuction is represented by Cryolipolysis, a non-invasive Aesthetic Medicine technique for body contouring. The Biotec Italia Medical team has patented Cryoliposculpt, an innovative device that stands out from other technologies on the market. This is a true evolution of cryolipolysis procedures, as also demonstrated by numerous ...
(NASDAQ: RCEL, ASX: AVH) (Company), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that a discussion on the RECELL System will be held during the Symposium for Cosmetic Advances & Laser Education (SCALE) multidisciplinary dermatology ...
The company also announces growth through a medical non-wound care vertical market expansion in Sports Medicine and Aesthetics. In a soft launch, SANUWAVE has already received over $1 million in purchase orders to be delivered in Q2 and Q3 2022. ...
(OTCPK: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing novel, next-generation injection technologies as well as regenerative medicine products in aesthetics and orthopedics, is pleased to announce a non-brokered private placement financing (the “Offering”) of up to 8,333,333 units (each, a ...
(OTCPK: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing novel, next-generation injection technologies as well as regenerative medicine products in aesthetics and orthopedics, is pleased to announce the filing of a new patent application covering novel aspects of the DermaPrecise™ product portfolio as ...
Belgian biotech company KiOmed Pharma has announced that it has entered into a worldwide (excluding USA) License and Supply Agreement with Sinclair Pharma, a global aesthetics company wholly owned by Huadong Medicine Company (HMC) Limited. ...
Taghizadeh is currently working with the Avra engineering group in the design and development of one of the world’s most sophisticated and versatile digital surgery platforms and will update the industry on the progress being made using a combination of imaging, guidance, targeting and intelligence to assist surgeons performing aesthetics and other skin resurfacing ...
Long before it was dubbed ‘Regenerative Medicine’, this type of medical intervention was applauded by healthcare professionals for its successful outcomes. ...